• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 624-638 of 971 results

2032 Exhibit: EX2032 US8309724

Document IPR2020-00040, No. 2032-49 Exhibit - EX2032 US8309724 (P.T.A.B. Aug. 20, 2020)

cite Cite Document
Analyze

2044 Exhibit: EX2044 WO2012166420

Document IPR2020-00040, No. 2044-53 Exhibit - EX2044 WO2012166420 (P.T.A.B. Aug. 20, 2020)

cite Cite Document
Analyze

1021 Exhibit: Decision, State of Israel Commissioner of Patents, Designs andEx 10...

Document IPR2020-01072, No. 1021 Exhibit - Decision, State of Israel Commissioner of Patents, Designs andEx 1021 Trademarks, Teva Pharmaceutical Industries Ltd Opposition to Merck Sharp Dohme...

cite Cite Document
Analyze

1020 Exhibit: Ex 1020 Complaint, Merck Sharp Dohme Corp v Dr Reddys Laborator...

Document IPR2020-01072, No. 1020 Exhibit - Ex 1020 Complaint, Merck Sharp Dohme Corp v Dr Reddys Laboratories, Inc et al, No 20 cv 00847 RGA, ECF 1 D Del June 24, 2020 (P.T.A.B. Jul. 29, 2020)

cite Cite Document
Analyze

1019 Exhibit: Ex 1019 Email from Merck to Joinder Petitioners Regarding Silent Un...

Document IPR2020-01072, No. 1019 Exhibit - Ex 1019 Email from Merck to Joinder Petitioners Regarding Silent Understudy Conditions (P.T.A.B. Jul. 29, 2020)

cite Cite Document
Analyze

1022 Exhibit: Ex 1022 Third Declaration of Leonard J Chyall, PhD

Document IPR2020-01072, No. 1022 Exhibit - Ex 1022 Third Declaration of Leonard J Chyall, PhD (P.T.A.B. Jul. 29, 2020)

cite Cite Document
Analyze

2030 Exhibit: EX2030 Excerpt of January 29, 2015 Trial Transcript with Dr Chyalls T...

Document IPR2020-01072, No. 2030 Exhibit - EX2030 Excerpt of January 29, 2015 Trial Transcript with Dr Chyalls Testimony (P.T.A.B. Jul. 10, 2020)

cite Cite Document
Analyze

2036 Exhibit: EX2036 20200702 Email from Mylan Reserving Rights

Document IPR2020-01072, No. 2036 Exhibit - EX2036 20200702 Email from Mylan Reserving Rights (P.T.A.B. Jul. 10, 2020)

cite Cite Document
Analyze

2039 Exhibit: EX2039 Teva Complaint

Document IPR2020-01072, No. 2039-2 Exhibit - EX2039 Teva Complaint (P.T.A.B. Jul. 10, 2020)

cite Cite Document
Analyze

2032 Exhibit: EX2032 US Patent No 8,309,724

Document IPR2020-01072, No. 2032 Exhibit - EX2032 US Patent No 8,309,724 (P.T.A.B. Jul. 10, 2020)

cite Cite Document
Analyze

2034 Exhibit: EX2034 Sun Pharm Indus Ltd Corporate Action Report

Document IPR2020-01072, No. 2034 Exhibit - EX2034 Sun Pharm Indus Ltd Corporate Action Report (P.T.A.B. Jul. 10, 2020)

cite Cite Document
Analyze

2039 Exhibit: EX2039 Teva Complaint

Document IPR2020-01072, No. 2039 Exhibit - EX2039 Teva Complaint (P.T.A.B. Jul. 10, 2020)

cite Cite Document
Analyze

2038 Exhibit: EX2038 20200707 Email from Joinder Petitioners

Document IPR2020-01072, No. 2038 Exhibit - EX2038 20200707 Email from Joinder Petitioners (P.T.A.B. Jul. 10, 2020)

cite Cite Document
Analyze

2027 Exhibit: EX2027 20200629 Email regarding Mylan Opposition to Schedule Ch...

Document IPR2020-01072, No. 2027 Exhibit - EX2027 20200629 Email regarding Mylan Opposition to Schedule Change (P.T.A.B. Jul. 10, 2020)

cite Cite Document
Analyze

2033 Exhibit: EX2033 WO 2013001457

Document IPR2020-01072, No. 2033 Exhibit - EX2033 WO 2013001457 (P.T.A.B. Jul. 10, 2020)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 42 43 44 45 46 ... >>